908 Devices Inc.

NASDAQ:MASS

Medical - Devices

Healthcare
$9.52 +2.51%

+$0.22 today

Market cap
$395.86M
Beta
0.64
P/E (TTM)
-9.0
EPS (TTM)
-$0.97
52W Low $5.03High $9.34

Volume 0.25M

Average 0.27M

MASS Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

908 Devices Inc.NASDAQ: MASS

Gross Margin · Q1 FY2026 · quarter ended Mar 2026

Gross margin widens to 47.7%

Gross margin was 47.7% in Q1 FY2026, up 0.6 pp from a year earlier. On a trailing-twelve-month basis it was 49.0%, down 1.6 pp year over year. Over 3 fiscal years it narrowed by 7.9 pp.

Context

  • Gross margin widened in 0 of the last 3 fiscal years.
  • FY2025 was the lowest level in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
47.7%-2.2 pp QoQ
Last fiscal yearDec 2025
47.7%-2.5 pp YoY
LTMMar 2026
49.0%-1.6 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+0.6 pp——
1 year-2.5 pp——
3 years-7.9 pp——
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2025
47.7%
Year-over-year change
-2.5pp

Gross Margin vs competitors

How MASS compares with its peers on the latest reported figures

  • MASS's LTM Mar 2026 gross margin of 49.0% is the lowest of the 3 companies compared; the peer median is 57.8%.
  • Its year-over-year change of -1.6 pp is the lowest of 3, against a peer median of -0.2 pp.
  • Over three fiscal years its change of -7.9 pp compares with a peer median of -2.4 pp.
MASS Competitors Peer median
Gross Margin for MASS and competitors
Company Period LTM level YoY 3-year change
QGENQiagen N.V.LTM Jun 202661.8% -1.1 pp-2.9 pp
AAgilent Technologies, Inc.LTM Jul 202653.7% +0.8 pp-1.9 pp
MASS908 Devices Inc.LTM Mar 202649.0% -1.6 pp-7.9 pp
Peer median (excluding MASS) 57.8%-0.2 pp-2.4 pp

Competitors are the stored peer set for MASS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue42.21M46.85M50.23M59.63M56.2M
Cost of Revenue18.97M20.83M24.91M29.71M29.4M
Gross Profit23.23M26.02M25.32M29.93M26.8M
Gross Margin55.0%55.5%50.4%50.2%47.7%
Research & Development13.07M17.53M21.9M25.5M13.8M
Selling, General & Admin32.24M43.88M0037.18M
Operating Expenses45.3M61.41M68.08M106.64M50.98M
Depreciation & Amortization925K1.61M2.38M4.68M4.47M
EBITDA(20.76M)(31.82M)(40.27M)(43.88M)(28.88M)
EBITDA Margin-49.2%-67.9%-80.2%-73.6%-51.4%
Operating Income(22.07M)(35.38M)(42.76M)(76.72M)(24.18M)
Operating Margin-52.3%-75.5%-85.1%-128.7%-43.0%
Interest Income548K2.03M6.48M4.49M4.14M
Interest Expense486K129K201K00
Other Income / Expenses(100K)1.82M6.15M4.23M(9.16M)
Income Before Tax(22.17M)(33.56M)(36.61M)(72.49M)(33.34M)
Pre-Tax Margin-52.5%-71.6%-72.9%-121.6%-59.3%
Income Tax Expense00(211K)(282K)(66K)
Net Income(22.17M)(33.56M)(36.4M)(72.21M)(36.64M)
Net Margin-52.5%-71.6%-72.5%-121.1%-65.2%
EPS (Basic)(0.79)(1.07)(1.13)(2.12)0.54
EPS (Diluted)(0.79)(1.07)(1.13)(2.12)0.54
Weighted Avg Shares27.96M31.49M32.21M34.08M36.22M
Weighted Avg Shares (Diluted)27.96M31.49M32.24M34.08M38.92M

908 Devices Inc.

NASDAQ:MASS

Intrinsic Alpha fair value

Locked

Current Price

$9.52

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.